株式会社AIメディカルサービス
Tokyo, JP · 5 known investors
AI Medical Service Inc. develops AI systems that support image-based diagnosis of endoscopy, primarily for detecting gastrointestinal cancers such as stomach and esophageal cancer. The Japan-based medical device company sells its gastroAI product line to endoscopy and gastroenterology settings, with operations expanding to the US and Southeast Asia.
AI & Machine LearningDigital HealthHealthtechMedical Devices
Founders & leadership
Investors · 5
Frequently asked questions
- What does 株式会社AIメディカルサービス do?
- AI Medical Service Inc. develops AI systems that support image-based diagnosis of endoscopy, primarily for detecting gastrointestinal cancers such as stomach and esophageal cancer. The Japan-based medical device company sells its gastroAI product line to endoscopy and gastroenterology settings, with operations expanding to the US and Southeast Asia.
- Who are 株式会社AIメディカルサービス's investors?
- 株式会社AIメディカルサービス's investors include Globis Capital Partners, WiL, Japan Post Capital Co. Ltd., SoftBank Vision Fund, Sony Ventures Corporation.
- Where is 株式会社AIメディカルサービス headquartered?
- 株式会社AIメディカルサービス is headquartered in Tokyo, JP.